Prescription Drugs
Members of Congress and industry experts talked about prescription drug access and costs. FDA Commissioner Scott Gottlie…
Rep. Gus Bilirakis (R,FL) questions Dr. Janet Woodcock on the use of new biomarkers in the approval of treatments by the FDA.
Members of Congress and industry experts talked about prescription drug access and costs. FDA Commissioner Scott Gottlie…
Food and Drug Administration Commissioner Dr. Robert Califf talked about the development of drug products derived from b…
Dr. Janet Woodcock testified at a hearing on the review and approval process for generic prescription drugs. She also ad…
Chief executive officers (CEOs) of several pharmaceutical companies and two Food and Drug Administration (FDA) officials…